I don't recall having seen a larger short volume %.
You may think that reflects a negative outlook for us, and I'm not going to try to dissuade you.
But at the same time, I think we have a few positive outcomes to look forward to this quarter, or next. These may be in regards to GvHD, CMML, a strategic alliance, and yes, even on covid, based on the ACTIV-5 analysis and the evolving regulatory and national defense interest of our country.
So in front of realizing those accomplishments, I want to repeat the opportunity I had from 2017 - 2021. In August 2017, I bought shares at $1.40, soon after we became "Humanigen."
In 2020, I added at an average of about $0.95. In March of 2021, I sold at $27.78 and $29.07. Subsequent purchases, such as in the $6 range, leave me with ~10X the number of shares I had, with a current average price of $1.19, and nothing to show for it for far too long. I won't even get a 1099 for last year, since there were no sell transactions.
Believe me, on my fixed income, I need some profitable sells after all this time.
My belief in the near-term realizations of our opportunities make me WANT to see increased short exposure, and even lower bids. That's just fuel for the fire when we blast off, with me holding as many shares as possible.